Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Kotak Mahindra Mutual Fund acquires stake in this recently listed healthcare stock
Kotak Mahindra Mutual Fund (KMMF) has raised its stake in the North Indian hospital network Park Medi World Limited to more than 5%. The fund purchased 175,164 shares, bringing its total ownership to 5.0393%, which necessitates a regulatory announcement in accordance with SAST regulations.
Buy or sell: Vaishali Parekh recommends three intraday stocks for today - 12 March 2026
The Indian stock market struggled on March 11, with significant losses in the Nifty 50 and BSE Sensex driven by high energy costs and inflation fears. Profit booking dominated all major sectors, especially autos and banking, as investors remained cautious amid geopolitical uncertainties.
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy and sell today - 10 March 2026
Shares to buy or sell: Chandan Taparia has recommended two stocks to buy today, 10 March 2026, and one stock to sell. Taparia recommends buying Torrent Pharmaceuticals and MCX shares today, while selling Maruti Suzuki stock futures.
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy and sell today - 10 March 2026 - Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy and sell today - 10 March 2026Mint
Stock market today: Trade setup for Gift Nifty 50, US-Iran war, crude oil, gold, silver rates — 8 stocks to buy or sell
Stock market today: Experts have recommended eight stocks to buy today — Reliance Industries, Balrampur Chini Mills, Jubilant FoodWorks, AB Capital, MCX, Ather Energy, Godrej Agrovet, and Yatharth Hospital
PE Firm True North Sells 3.6% Stake In Anthem Biosciences For Rs 1,261 Crore
HDFC Mutual Fund (MF) and SBI MF have collectively acquired 93,01,020 shares or 1.65% holding in Anthem Biosciences at an average price of Rs 621.10 apiece.
Market Trading Guide: Apollo Pipes among 3 stock recommendations for Tuesday
Sensex and Nifty plunged nearly 2% as rising crude oil prices, weak global cues and escalating West Asia tensions triggered heavy selling. Foreign fund outflows and a weaker rupee added pressure. Analysts recommend Apollo Pipes, Aurobindo Pharma and Tata Steel for potential short-term gains.
Market Trading Guide: Buy Balrampur Chini and Abbott India on Thursday for gains up to 5%
The Nifty fell 1.6% amid broad-based selling triggered by the Iran-Israel conflict, with financials, auto and energy stocks leading losses. Analysts flag weak momentum and advise a sell-on-rise approach, while recommending Balrampur Chini Mills and Abbott India for short-term gains.
Laurus Labs shares are up 100% in the last 12 months and Motilal Oswal sees further upside
Motilal Oswal expects Laurus Labs to end financial year 2026 with a Profit After Tax (PAT) of ₹850 crore and reach ₹1,150 crore by financial year 2028, implying a Compounded Annual Growth Rate (CAGR) of 16% by this period.
Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026 - Mint
Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026Mint
Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026
Shares to buy or sell: Chandan Taparia has recommended two stocks to buy today, 20 February 2026 - Oil and Natural Gas Corporation (ONGC) and RBL Bank shares - and has suggested selling Info Edge (India) stock futures.
Buy Rubicon Research; target of Rs 1160: Motilal Oswal
Motilal Oswal is bullish on Rubicon Research recommended buy rating on the stock with a target price of Rs 1160 in its research report dated May 30, 2026.